Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA–peptide complexes in systemic lupus erythematosus

…, G Chamilos, R Sebasigari, V Riccieri… - Science translational …, 2011 - science.org
Systemic lupus erythematosus (SLE) is a severe and incurable autoimmune disease
characterized by chronic activation of plasmacytoid dendritic cells (pDCs) and production of …

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

…, G Szucs, CA Von Mühlen, V Riccieri… - Annals of the …, 2010 - ard.bmj.com
Objectives To determine the causes and predictors of mortality in systemic sclerosis (SSc).
Methods Patients with SSc (n=5860) fulfilling the American College of Rheumatology criteria …

[HTML][HTML] The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis

…, B Marinari, S Chon, L Vence, V Riccieri… - Nature …, 2014 - nature.com
Psoriasis is a common T-cell-mediated skin disease with 2–3% prevalence worldwide. Psoriasis
is considered to be an autoimmune disease, but the precise nature of the autoantigens …

Mapping and predicting mortality from systemic sclerosis

…, N Damjanov, MJ Salvador, V Riccieri… - Annals of the …, 2017 - ard.bmj.com
Objectives To determine the causes of death and risk factors in systemic sclerosis (SSc).
Methods Between 2000 and 2011, we examined the death certificates of all French patients …

Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group

J Avouac, J Fransen, UA Walker, V Riccieri… - Annals of the …, 2011 - ard.bmj.com
Objective To identify a core set of preliminary items considered as important for the very
early diagnosis of systemic sclerosis (SSc). Methods A list of items provided by European …

Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic …

…, A Komócsi, D Farge, A Balbir, V Riccieri… - Annals of the …, 2010 - ard.bmj.com
Objectives: To measure the prevalence of, and factors associated with, left ventricular (LV)
dysfunction in systemic sclerosis (SSc). Methods: The EUSTAR database was first searched. …

[HTML][HTML] Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis

…, S Paolino, C Pizzorni, M Radic, V Riccieri… - Autoimmunity …, 2020 - Elsevier
Capillaroscopy is a non-invasive and safe tool which allows the evaluation of the morphology
of the microcirculation. Since its recent incorporation in the 2013 American College of …

[HTML][HTML] Genome-Wide Scan Identifies TNIP1, PSORS1C1, and RHOB as Novel Risk Loci for Systemic Sclerosis

…, C Conti, M Müller, U Müller-Ladner, V Riccieri… - PLoS …, 2011 - journals.plos.org
Systemic sclerosis (SSc) is an orphan, complex, inflammatory disease affecting the immune
system and connective tissue. SSc stands out as a severely incapacitating and life-…

“To be or not to be,” ten years after: evidence for mixed connective tissue disease as a distinct entity

…, CG Kiss, AK Tausche, S Cardarelli, V Riccieri… - Seminars in arthritis and …, 2012 - Elsevier
OBJECTIVES: To determine if mixed connective tissue disease (MCTD) can be considered
an independent clinical entity, to compare 3 different classification criteria for MCTD (…

Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study

…, F Bartoli, G Fiori, M Bokarewa, V Riccieri… - Annals of the …, 2013 - ard.bmj.com
Objective To evaluate the safety and effectiveness of tocilizumab and abatacept in systemic
sclerosis (SSc)-polyarthritis or SSc-myopathy. Methods 20 patients with SSc with refractory …